Paul Sonnier

Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL.

Deep Water Point LLC provides consulting services. It offers market intelligence and analysis, business development, capture management and proposal support, strategic account planning and sales support, messaging and requirements alignment with funding initiatives, competitive analysis, channel partner model optimization and general business model advisory services. The company was founded by Howard C. Seeger in 2002 and is headquartered in McLean, VA.

Ablative Solutions, Inc. develops and markets endovascular catheters for the treatment of hypertension. It offers solutions for heart failure, kidney disease, metabolic syndrome, and sleep apnea. The company was founded by Tim A. Fischell and David R. Fischell in 2011 and is headquartered in San Jose, CA.

BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Riverside Partners LLC (Riverside Partners) is a private equity firm founded in 1989. The firm is headquartered in Boston, Massachusetts.

MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium.

NDA Partners LLC provides strategy consulting services. It also provides a comprehensive range of services across the product development life cycle for drugs, biologics, biosimilars, vaccines, generics, devices, combination products and diagnostics. The company was founded by Carl C. Peck and Earle Martin and is headquartered in Annapolis, MD.

OPKO Diagnostics LLC engages in the provision of health services. It develops blood testing devices for use in homes and doctors offices. The company was founded by Vincent Linder, George M. Whitesides, David Steinmiller, and Samuel K. Sia in 2004 and is headquartered in Woburn, MA.

Fairway Medical Technologies, Inc. operates as a holding company that designs, develops, and manufactures medical devices. It specializes in the development and marketing of life support blood pump and console technologies. The firm offers its products and services for allergy testing, antibiotic sensitivity, blood gas, blood pressure monitoring, blood typing, computer-aided design engineering, cardiac assist, capillary imaging, cell and particle counting, cell differentiation, centrifugation, diluting and dispensing, DNA sequencing and synthesis, heat therapy, infrared imaging, membrane technology, optoacoustics, and motion therapeutics. The company was founded by Yukihiko Nose in 1992 and is headquartered in Houston, TX.

Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX.

Global Interconnect, Inc. manufactures electronic cables.

RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA.

Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London.

AX Enterprize LLC specializes in hardware, software and systems engineering and light electro-mechanical manufacturing. It also designs and develops hardware components and cable harnesses (copper and fiber) for airborne, land vehicle assets and terrestrial installations. The company is headquartered in Yorkville, NY.

BioAgilytix Labs LLC engages in the provision of specialized bioanalytical testing laboratory. It offers gene therapy, biosimilars, antibody drug conjugates and immuno-oncology solutions. The company was founded by Afshin Safavi in 2008 and is headquartered in Durham, NC.

StepStoneMed, Inc. develops software which acquires and retain clinical knowledge and recall patient care protocols. Its software is used by the physicians, nurses, medical students, aides and volunteers. The company was founded by David Eagleman and Matthew Timberlake in 2009 and is headquartered in Houston, TX.

Diversigen, Inc. provides microbiome and metagenomics services. The firm also offers data analysis, focused on solutions to improve human and animal health, environmental conditions and agriculture production worldwide. It offers metagenomics, single organism genome, microbial RNA, and viral metagenomics sequencing services. The company was founded by Joseph F. Petrosino in 2013 and is headquartered in Houston, TX.

BALX Holdings LLC operates as a biotechnology firm which offers health care services. The company was incorporated in 2013 and is headquartered in Boston, MA.

Cardiocube Corp. develops healthcare system software. The American company was founded by Oscar Kiwic, Chris Grabowski, Rodney Anderson, Tom Jadczyk, Przemek Magaczewski. Oscar Kiwic has been the CEO since incorporation.

Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019.

Anizome LLC is a private company based in Houston. The American company provides a description of their services in non-English text, which appears to be related to online sports betting and casino games.

Part of Healius Ltd., Agilex Biolabs Pty Ltd. is a bioanalytical and toxicology laboratory based in Thebarton, Australia. The Australian company has been in the industry for 25 years and is known for delivering bioanalytical services for nonclinical and clinical trials with international research standards. Agilex has accelerated hundreds of trials worldwide with reliable and defendable toxicology studies, clinical bioanalysis, and biomarker data to improve human health. Jason Valentine has been the CEO of the company since 2019. Agilex Biolabs was acquired by Healius Ltd. on February 01, 2022 for $216.62 million.

Avance Clinical Pty Ltd. is a premium full-service CRO that delivers quality clinical trials for international biotechs. Avance Clinical is based in Thebarton, AU, and has subsidiaries in the United States. The Australian company provides fast, agile, and adaptive solution-oriented clinical research services to biotechs in their drug development phases. The CEO of the company is Yvonne Lungershausen.

Mabvista, Inc. is a biotechnology firm that specializes in producing monoclonal antibodies. The company is based in Houston, TX.